Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive immunity

Neuroendocrinology Letters

Volumn 27, Issue SUPPL. 2, 2006, Pages 160-163

  Pečivová, Jana ^a   Mačičková, Tatiana ^a   Lojek, Antonín ^b   Gallová, Lucia ^b   Číž, Milan ^b   Nosál', Rado ^a   Holomáňová, Dagmar ^c  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c National Transfusion Service   (Slovakia)

Author keywords

Carvedilol; Myeloperoxidase; Phagocytes; Reactive oxygen species

Indexed keywords

CARVEDILOL; CYTOCHROME C; DIANISIDINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; WORTMANNIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIOXIDANT ACTIVITY; CELL STIMULATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; ENZYME RELEASE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; OXIDATION; PHAGOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

EID: 34047217934     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Arnhold J. Free radicals - friends or foes? Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Moscow). 2004; 69: 4-9.
2. Asbrink S, Zickert A, Bratt J, Gyllenhammar H, Palmblad J. No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions. Biochem Pharmacol. 2000; 59:1007-13.
3. Cheng J, Kamiya K, Kodama I. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential. Cardiovasc Drug Rev. 2001; 19:152-71.
4. Escobales N and Crespo MJ. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol. 2005; 3:231-46.
5. Fleming I, Busse R. The physiology of nitric oxide: Control and consequences. Curr Med Chem-Anti-Inflammatory & Anti-Allergy Agents. 2004; 3:89-205.
6. Galijasevic S, Saed GM, Diamond MP, Abu- Soud HM. Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proc Natl Acad Sci USA. 2003; 100:14766-71.
7. Gallova L, Pavelkova M, Macickova T, Nosal R, Ciz M, Lojek A.The influence of carvedilol on the production of reactive oxygen and nitrogen species by phagocytes. Biologia. 2005; 60:127-30.
8. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med. 2004; 351: 2112-4.
9. Marasco W, Phan SH, Krutzsch H, Showel HJ, Feltner DE, Nairn R, et al. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem. 1984; 259:5430-9.
10. Munzel T., Hink U., Heitzer T., Meinertz T.. Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann N Y Acad Sci. 1999; 874:386-400.
11. Nosál' R, Jančinová V, Číž M, Drábiková K, Lojek A, Fabryová V. Inhibition of chemiluminescence by carvedilol in the cell-free system, whole human blood and blood cells. Scand J Clin Lab Invest. 2005; 65:55-64.
12. Sethi S, Dikshit M. Modulation of polymorphonuclear leukocytes function by nitric oxide. Thrombosis Research. 2000; 100:223-47.
13. Vocks A, Petkovic M, Arnhold J. Involvement of phospatidic acid in both degranulation and oxidative activity in fMet-Leu-Phe stimulated polymorphonuclear leukocytes. Cell Physiol Biochem. 2003; 13:165-72.